2011 PCF Challenge Award

Howard Scher, MD –:

Memorial Sloan-Kettering Cancer Center
Development of Combined Inhibition of AR and PI3K Signaling as a Therapeutic Strategy for Advanced Prostate Cancer

Co-Investigators:

Charles Sawyers, MD; Brett Carver, MD; Neal Rosen, MD, PhD

Martin Sanda, MD –:

Beth Israel Deaconess Medical Center
Nanoparticle-Targeted Peptide Vaccines for Prostate Cancer: The Harvard – Hopkins – Carolina Consortium

Co-Investigators:

Joseph M DeSimone, PhD; Simon M Arredouani, PhD; Charles Drake, MD, PhD

Christopher J. Logothetis, MD –:

The University of Texas MD Anderson Cancer Center Mechanisms of Resistance to Androgen Biosynthesis Inhibition in Castration-Resistant Prostate Cancer Bone Metastases

Co-Investigators:

Gary Gallick, PhD; Sankar Maity, PhD; Randall Millikan, MD, PhD; Mark Bedford, PhD; Eleni Efstathiou, MD, PhD

Philip G. Febbo, MD –:

University of California, San Francisco
Understanding the Clinical and Radiological Impact of XL184 through Treatment Science

Co-Investigators:

Celestia Higano, MD, Beatrice Knutson, PhD, Peter Nelson, MD, Edwin Posadas, MD, Ravi Salgia, MD, Evan Yu, MD

Leland W.K . Chung, PhD –:

Cedars-Sinai Medical Center
Targeting Cell Death Programs in the Tumor and its Microenvironment

Co-Investigators:

Edwin Posadas, MD; Neil Bhowmick, PhD; Hyung L Kim, MD;
Andre Rogatko, PhD; Beatrice Knudsen, MD, PhD; Stuart Holden, MD; Mahul B. Amin, MD; Martin Gleave, MD; Michael Freeman, PhD; Daqing Wu, PhD; Matthew Bui, MD

Institution:

Institute of Cancer Research

Discipline:

Medical Oncology